Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 127 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 02/28/17
Due: 02/28/18
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 07/31/19
End: 07/31/20
Due: 07/31/21
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 03/31/09
Due: 03/31/10
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 10/31/09
Due: 10/31/10
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 11/30/13
Due: 11/30/14
Phase: N/A
Priority: Normal
Start: 07/01/21
End: 07/30/22
Due: 07/30/23
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 05/31/23
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 10/01/24
Due: 10/01/25
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 10/01/23
End: 03/01/24
Due: 03/01/25
Phase: N/A
Priority: Normal
Start: 03/31/06
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 10/31/16
End: 03/31/19
Due: 03/31/20
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 05/31/13
Due: 05/31/14
Phase: N/A
Priority: Normal
Start: 06/15/20
End: 10/05/20
Due: 10/05/21
Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia
Phase: N/A
Priority: Normal
Start: 06/30/07
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 05/31/10
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 01/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/01/19
End: 04/01/21
Due: 04/01/22